Perinatal Diagnosis of GIT Anomalies

Fetal Anomalies Clinical Trial

Official title:

Perinatal Diagnosis of Fetal GIT Anomalies

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03514940
• Other study ID #: GIT
• Status: Recruiting
• Start date: May 2, 2018
• Est. completion date: July 7, 2020

Study information

• Verified date: January 2020
• Source: Aljazeera Hospital
• Contact: Mahmoud Alalfy
• Phone: 01002611058
• Email: mahmoudalalfy[@]ymail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

fetal gastro intestinal abnormalities can be accurately diagnosed in second trimester

Description:

prenatal diagnosis of these anomalies allows for early postnatal interventions and implementation of treatment options

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 130
• Est. completion date: July 7, 2020
• Est. primary completion date: June 3, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 20 Years to 40 Years

Eligibility

Inclusion Criteria:

• pregnant women either primi or multigravida

• pregnant in 18- 24 weeks

Exclusion Criteria:

• first trimester pregnant ladies

Related Conditions & MeSH terms

• Congenital Abnormalities
• Fetal Anomalies

Intervention

Diagnostic Test:
• ultrasound
second trimester us scan will be made to pregnant women

Locations

Country	Name	City	State
Egypt	Algazeerah	Giza

Sponsors (3)

Lead Sponsor	Collaborator
Aljazeera Hospital	Kasr El Aini Hospital, National Research Center, Egypt

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The number of participants who will be diagnosed to have GIT anomalies	GIT anomalies that will be diagnosed by US and confirmed postnatal and managed operatively	within 5 moths